Skip to main content
. 2013 Jul 25;288(35):25638–25645. doi: 10.1074/jbc.M113.494955

FIGURE 8.

FIGURE 8.

Possible mechanism of action of RB150, a brain-targeting APA inhibitor. RB150 is an orally available prodrug, can pass the blood-brain barrier, and is converted to its active form (EC33) inside the brain (18). Potential interactions between EC33 and human APA are shown schematically.